Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 10 May 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 12 Jan 2012 Planned End Date changed to 1 Feb 2007 as reported by University Hospital Medical Information Network - Japan.
- 06 Jun 2009 New trial record.